461 results on '"Breneman, John"'
Search Results
52. Local control and outcome in children with localized vaginal rhabdomyosarcoma: A report from the Soft Tissue Sarcoma committee of the Childrenʼs Oncology Group
53. EPCT-16. A PHASE IB STUDY OF PTC596 IN CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA AND HIGH GRADE GLIOMA
54. Genome-Driven Therapy for Chemotherapy-Resistant MetastaticCDK6-Amplified Osteosarcoma
55. Introduction to the COG/SIOP/PROS supplement on radiation oncology
56. Practice patterns and recommendations for pediatric image‐guided radiotherapy: A Children's Oncology Group report
57. Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
58. Pediatric Central Nervous System Germinoma: What Can We Understand From a Worldwide Effort to Maximize Cure and Minimize Risk?
59. A Fully Automated Multiplex Assay for Diagnosis of Lyme Disease with High Specificity and Improved Early Sensitivity
60. Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV
61. Results in Patients With Cranial Parameningeal Sarcoma and Metastases (Stage 4) Treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II–IV, 1978–1997: Report From the Children's Oncology Group
62. Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: A Childrenʼs Oncology Group study (CCG-1941)
63. Bone Marrow Transplantation Versus Prolonged Intensive Chemotherapy for Children With Acute Lymphoblastic Leukemia and an Initial Bone Marrow Relapse Within 12 Months of the Completion of Primary Therapy: Childrenʼs Oncology Group Study CCG-1941
64. Organization of centromeres in the decondensed nuclei of mature human sperm
65. Plaque radiotherapy for choroidal and ciliochoroidal melanomas with limited nodular extrascleral extension
66. Should multiple lymph node biopsies be taken?
67. LARGE SPHENOID WING MENINGIOMAS INVOLVING THE CAVERNOUS SINUS: CONSERVATIVE SURGICAL STRATEGIES FOR BETTER FUNCTIONAL OUTCOMES
68. Failure Pattern and Factors Predictive of Local Failure in Rhabdomyosarcoma: A Report of Group III Patients on the Third Intergroup Rhabdomyosarcoma Study
69. Lymph node grading for staging of mycosis fungoides may benefit from examination of multiple excised lymph nodes
70. Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV
71. Which Patients With Microscopic Disease and Rhabdomyosarcoma Experience Relapse After Therapy? A Report From the Soft Tissue Sarcoma Committee of the Children’s Oncology Group
72. Routine Brain Imaging Is Unwarranted in Asymptomatic Patients with Rhabdomyosarcoma Arising Outside of the Head and Neck Region That Is Metastatic at Diagnosis: A Report From the Intergroup Rhabdomyosarcoma Study Group
73. Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease
74. Up-Front Window Trial of Topotecan in Previously Untreated Children and Adolescents With Metastatic Rhabdomyosarcoma: An Intergroup Rhabdomyosarcoma Study
75. Benefit of Intensified Therapy for Patients With Local or Regional Embryonal Rhabdomyosarcoma: Results From the Intergroup Rhabdomyosarcoma Study IV
76. Permanent Iodine-125 Interstitial Implants for the Treatment of Recurrent Glioblastoma Multiforme
77. Pediatric Radiation Therapy—When Too Much Is Not Enough
78. Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941–August 10, 2018
79. Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group
80. Stereotactic radiosurgery for the treatment of brain metastases: results of a single institution series
81. Topical mechlorethamine in the treatment of mycosis fungoides: uniformity of application and potential for environmental contamination
82. Reirradiation in Pediatric Patients With Recurrent Brain Tumors: A Last Hope, But One With Greatly Feared Consequences
83. Larry Emanuel Kun, March 10, 1946-May 27, 2018
84. Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group
85. Genome-Driven Therapy for Chemotherapy-Resistant Metastatic CDK6-Amplified Osteosarcoma.
86. Ventricular violation increases the risk of leptomeningeal disease in cavity-directed radiosurgery treated patients
87. Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative Groups
88. Sentinel lymph node biopsy in head and neck rhabdomyosarcoma
89. Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma (RMS): Analysis of Children’s Oncology Group (COG) Protocols ARST 0331 and ARST0531
90. The Children's Oncology Group Radiation Oncology Discipline: 15 Years of Contributions to the Treatment of Childhood Cancer
91. DIPG-73. CLEE011XUS17T (NCT 02607124): A PHASE I/II STUDY OF RIBOCICLIB (LEE011) FOLLOWING RADIATION THERAPY (RT) IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED NON-BIOPSIED DIFFUSE PONTINE GLIOMAS (DIPG) AND RB+ BIOPSIED DIPG AND HIGH GRADE GLIOMAS (HGG)
92. An Update From the Pediatric Proton Consortium Registry
93. Stereotactic Radiosurgery for Resected Brain Metastases: New Evidence Supports a Practice Shift, but Questions Remain
94. Contributors
95. Chapter 75 - Rare Pediatric Tumors
96. Treatment of Gliomas: A Changing Landscape
97. (P104) Radiation and Subsequent Reirradiation Outcomes in the Treatment of Diffuse Intrinsic Pontine Glioma and a Systematic Review of the Reirradiation Literature
98. DIPG-27. CLEE011XUS17T (NCT 02607124): A PHASE I/II STUDY OF RIBOCICLIB (LEE011) FOLLOWING RADIATION THERAPY IN CHILDREN WITH NEWLY DIAGNOSED NON-BIOPSIED DIFFUSE PONTINE GLIOMAS (DIPG) AND RB+ BIOPSIED DIPG AND HIGH GRADE GLIOMAS (HGG)
99. Design of a cap for radioshielding during treatment with interstitial125I brain implants
100. Reduction of cyclophosphamide dose for patients with subset 2 low‐risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.